CYP3A4 and familial long QT syndrome: More discrete analyses were performed for both the CYP450 drug interaction burden and LQTS score as these two factors were significantly modified by CYP3A4 inhibitors and strong CYP3A4 affinity substrates: as iclepertin is expected to exhibit a weak affinity towards CYP3A4, it would behave like a victim drug.